Cargando…
SETD7 is a prognosis predicting factor of breast cancer and regulates redox homeostasis
SETD7 is a methyltransferase that specifically catalyzes the monomethylation of lysine 4 on histone H3. A variety of studies has revealed the role of SETD7 in posttranslational modifications of non-histone proteins. However, the prognostic value of SETD7 on breast cancer and the ability of SETD7 of...
Autores principales: | Huang, Run, Li, Xiaolin, Yu, Yang, Ma, Lisi, Liu, Sixuan, Zong, Xiangyun, Zheng, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706857/ https://www.ncbi.nlm.nih.gov/pubmed/29212211 http://dx.doi.org/10.18632/oncotarget.21583 |
Ejemplares similares
-
Can Anti-Müllerian Hormone Be a Reliable Biomarker for Assessing Ovarian Function in Women Postchemotherapy?
por: Li, Xiaolin, et al.
Publicado: (2020) -
GnRHa protects the ovarian reserve by reducing endoplasmic reticulum stress during cyclophosphamide-based chemotherapy
por: Li, Xiaolin, et al.
Publicado: (2021) -
The Epigenetic Regulation of Nonhistone Proteins by SETD7: New Targets in Cancer
por: Chiang, Chengyao, et al.
Publicado: (2022) -
The roles of anti-Müllerian hormone in breast cancer
por: Chen, Xuan, et al.
Publicado: (2023) -
SETD7 Regulates the Differentiation of Human Embryonic Stem Cells
por: Castaño, Julio, et al.
Publicado: (2016)